Research Article

Related GMR Articles

10/27/2015
BRCA1; BRCA2; Breast cancer; Kazakh; mutations

Mutations in the BRCA1/2 genes are associated with an increased risk of breast cancer, but no large-scale research have examined the BRCA1/2 mutations in Chinese Kazakh women. We evaluated the frequency and distributions of BRCA1 and BRCA2 gene mutations in Kazakh sporadic breast cancer patients and healthy women in China. The association between the clinical-pathologic features ... more

S.Y. Yang; D. Aisimutula; H.F. Li; Y. Hu; X. Du; J. Li; M.X. Luan
12/14/2015
Breast cancer; KRAS; let-7; Polymorphism

Breast cancer (BC) is a common malignancy affecting women, with increasing incidences of this disease in China every year. Recent studies have extensively investigated a single nucleotide polymorphism in the let-7 miRNA binding site of the 3'-untranslated region of KRAS mRNA. The aim of this study was to determine the genotype frequency of the KRAS rs712 polymorphism, ... more

X. Huang; Y. Yang; Y. Guo; Z.L. Cao; Z.W. Cui; T.C. Hu; L.B. Gao
07/03/2015
BRAF; Gene mutation; Lymph node metastasis; Papillary thyroid carcinoma

This study sought to investigate the correlations of V-raf murine sarcoma viral oncogene homolog B1 (BRAF) gene mutations with the clinicopathologic features of papillary thyroid carcinoma and central lymph node metastasis. We retrospectively analyzed the 2-year medical records of patients who underwent surgery for papillary thyroid carcinoma. After screening, the records of 126 patients ... more

C.L. Shi; Y. Sun; C. Ding; Y.C. Lv; H.D. Qin
09/09/2015
c-Myc; KRAS; Mucinous; Ovarian tumor

We examined the expression of c-myc and mutations in the KRAS gene in ovarian mucinous tumors to explore the pathogenesis of these tumors and the feasibility of targeted gene therapy. Expression of c-myc protein and mutations in the KRAS gene in 24 cases of ovarian mucinous cystadenoma, 46 cases of ovarian borderline mucinous cystadenoma, and 46 cases of ovarian mucinous ... more

X.S. Li; J. Sun; X.L. He
10/30/2015
Genetics; Hepatocellular carcinoma; KRAS; Polymorphisms

KRAS, also known as V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog, acts as an intracellular signal transducer. The oncogenic KRAS mutation is an essential step in the development of many types of human cancers, including hepatocellular carcinoma. Here we aimed to investigate the relationship between KRAS rs712 polymorphisms and hepatocellular carcinoma ... more

D. Xiong; Y.P. Song; W. Xiong; Y.D. Liang
07/29/2016
Acquired drug-resistance; Pancreatic cancer; Pemetrexed; PI3K/Akt signal transduction pathway; PIK3CA; PTEN

The aim of this study was to investigate the expression of PTEN and PIK3CA in the pemetrexed-resistant human pancreatic cancer cell line Patu8988, and to evaluate their effects on the biological behavior of pancreatic cancer cells. PTEN and PIK3CA gene and protein expressions were detected by reverse transcriptase polymerase chain reaction (RT-PCR) and western blot, respectively, in a ... more

X. Shi; H.T. Gu; S.B. Lin; Y. Zhang; J. Yang; C.J. Qian; X. Shi; H.T. Gu; S.B. Lin; Y. Zhang; J. Yang; C.J. Qian
01/25/2011
Gene; Mutation; TSC1; Tuberous sclerosis complex

Tuberous sclerosis complex is an autosomal-dominant heritable disease caused by mutations in the TSC1 and TSC2 genes. We studied a Chinese patient with sporadic tuberous sclerosis complex. The clinical features of this patient included epilepsy, hypomelanotic macules and angiofibromas on his back; a cranial CT scan showed subependymal nodules along the lateral walls of the ... more

G.X. Wang; D.W. Wang; J.S. Zhao; S.F. Wang; R.P. Sun
11/22/2013
Biomarker; Mutation; Myelodysplastic syndromes; Refractory cytopenias with multilineage dysplasia; TET2

Myelodysplastic syndrome diagnosis of karyotypically normal patients may be elusive because it relies exclusively on morphological and clinical data. In routine practice, finding of an acquired mutation or a cytogenetic abnormality provides irrefutable evidence of the clonal nature of that disease. Recurrent deletions and somatic mutations in TET2, a gene involved in epigenetic ... more

D.F. Coutinho; C. Diniz; R.L.D. Filgueiras; R.L.R. Baptista; J.P. Ayres-Silva; B.C.R. Monte-Mór; M.H. Bonamino; I.R. Zalcberg
05/18/2012
Charcot-Marie-Tooth; Gender; Mitofusin 2; Mutation

Charcot-Marie-Tooth (CMT) is a group of clinically and genetically heterogeneous inherited neuromuscular disorders. At present, more than 30 loci have been reported to be associated with CMT disease; point mutations in the mitofusin 2 (MFN2) gene is one of the most common causes. We studied a Chinese family with CMT disease in which the phenotype of affected individuals varied, and the ... more

Y.W. Wang; W.T. Han; M. Jiang; C.X. Lu; X.F. Li; X. Zhang; J.X. Li
09/21/2015
Autosomal dominant optic atrophy; Copy number variation; Mutation; Optic atrophy protein 1; Pedigree

Autosomal dominant optic atrophy (ADOA) is an optic neuropathy characterized by bilateral optic nerve pallor and decreased visual acuity. It has been reported to be associated with two genes, OPA1, OPA3, and the OPA4, OPA5, and OPA8 loci. However, mutations in OPA1 constitute the most prevalent cause of ADOA. The purpose of this study ... more

X. Jin; Y.H. Chen; Z. Liu; Y. Deng; N.N. Li; H. Huang; M. Qi; X. Yi; J. Zhu

Pages